EPITRANSCRIPTOMIC ANALYSIS OF GLIOMA
The present disclosure relates to the field of epitranscriptomic signatures to determine glioma progression versus glioma pseudoprogression. Further, wherein identifying whether a subject has a progressive glioma or a pseudoprogressive glioma, the method comprising: a. isolating a tissue biopsy from...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present disclosure relates to the field of epitranscriptomic signatures to determine glioma progression versus glioma pseudoprogression. Further, wherein identifying whether a subject has a progressive glioma or a pseudoprogressive glioma, the method comprising: a. isolating a tissue biopsy from the subject; b. detecting an altered N6-Methyladenosine (m6A) epigenetic modification on an mRNA from the tissue biopsy is disclosed.
La présente divulgation concerne le domaine des signatures épitranscriptomiques pour déterminer la progression d'un gliome par rapport à une pseudo-progression de gliome. |
---|---|
Bibliography: | Application Number: WO2023US30443 |